Insider · CIK 0002131608
Nan (LN) Li
Files at ODTX (Odyssey Therapeutics, Inc.). First filing May 11, 2026, latest May 11, 2026.
In brief
Nan (LN) Li files SEC Form 4 as director at ODTX (Odyssey Therapeutics, Inc.). Since May 11, 2026, Nan (LN) Li has reported 1 open-market buy worth $20M and 0 open-market sells worth $0, the latest filed on May 11, 2026.
A track record needs three past buys with six months of prices behind them; Nan (LN) Li has 0, so none is measured yet.
The newest scored trade: bought $20M of ODTX on May 11, 2026, filed May 11, 2026, scored 61 (notable). In the last 12 months: 1 buy worth $20M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ODTX: Odyssey Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Odyssey Therapeutics, Inc. | $20M 1,111,111 shares | +50% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | CConversion Common Stockindirect: See footnote | +1,709,543 | - | - | 2,222,405 | May 11, 2026 |
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See footnote | +1,111,111 | $18.00 | $20M | 3,333,516 | May 11, 2026 |
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | CConversion Series D Convertible Preferred Stockderivativeindirect: See footnote | -16,611,626 | - | - | 0 | May 11, 2026 |
Questions about Nan (LN) Li
Answered from the filings on this page, as of the latest one.
Is Nan (LN) Li buying or selling?
In the last 12 months Nan (LN) Li reported 1 open-market buy worth $20M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20M of ODTX on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Nan (LN) Li's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nan (LN) Li has 0.
Where does Nan (LN) Li file Form 4?
Nan (LN) Li has filed Form 4 at ODTX (Odyssey Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.